US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

40.47

-0.0534-0.13%

Post-market: 40.45-0.0166-0.04%19:30 EDT

Volume:20.38K

Turnover:826.15K

Market Cap:1.04B

PE:- -

High:40.86

Open:40.86

Low:40.41

Close:40.52

52wk High:42.87

52wk Low:27.30

Shares:25.75M

Float Shares:25.75M

Volume Ratio:0.69

T/O Rate:0.08%

Dividend:0.43

Dividend Rate:1.05%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Protagonist Therapeutics Launches USD 300 Million Share Buyback Program

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Headlands Research Names Brandon Pallott Chief Commercial Officer

Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.25% on Sep 8: Facts Behind the Movement

Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback

Dow Drops 438 Points on Losses for Amgen, Salesforce Shares

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

Johnson & Johnson Innovation Names Silvia Chen Head of JLABS Shanghai

Bristol Myers Squibb's Phase 2 Study of Arlocabtagene Autoleucel Meets Key Endpoints

MT Newswires Live

Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial

Bristol Myers Squibb's Therapy Meets Mid-Stage Trial Goal

Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 Quintessential Trial of the Potential First-in-Class Gprc5d-Directed Car T Cell Therapy, Arlocabtagene Autoleucel ...

THOMSON REUTERS

Bristol-Myers Squibb Company - Phase 2 Trial Met Primary Endpoint of Overall Response Rate and Complete Response Rate

THOMSON REUTERS

Bristol-Myers Squibb Company - Arlo-Cel Safety Profile Consistent with Other Car T Cell Therapies

THOMSON REUTERS

Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.

Merck CEO Davis, R&D Head Li to Speak at Morgan Stanley Global Healthcare Conference

Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating

MT Newswires Live

Abbvie : Bofa Global Research Raises Price Objective to $282.00 from $276.00

THOMSON REUTERS

Merck & Co Inc : Guggenheim Raises Target Price to $170 from $146

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/FTXH/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FTXH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","market":"US","secType":"STK","nameCN":"First Trust Nasdaq Pharmaceuticals ETF","latestPrice":40.4666,"timestamp":1789156800000,"preClose":40.52,"halted":0,"volume":20380,"hourTrading":{"tag":"盘后","latestPrice":40.45,"preClose":40.4666,"latestTime":"19:30 EDT","volume":10,"amount":404.7662,"timestamp":1789169407280,"change":-0.0166,"changeRate":-0.00041,"amplitude":0},"delay":0,"changeRate":-0.0013178677196447048,"floatShares":25750002,"shares":25750002,"eps":0,"marketStatus":"Market Closed","change":-0.0534,"latestTime":"09-11 16:00:00 EDT","open":40.86,"high":40.86,"low":40.4101,"amount":826153.51632,"amplitude":0.011103,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":40.52,"sharesOutstanding":850002,"nav":40.44,"aum":1043352080.88,"dividendRate":0.010515,"bidAskSpread":0.001712,"postHourTrading":{"tag":"盘后","latestPrice":40.45,"preClose":40.4666,"latestTime":"19:30 EDT","volume":10,"amount":404.7662,"timestamp":1789169407280,"change":-0.0166,"changeRate":-0.00041,"amplitude":0},"volumeRatio":0.6949275072918909,"impliedVol":0.059,"impliedVolPercentile":0.506},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","floatShares":25750002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6949275072918909,"shares":25750002,"dividePrice":0.4255,"high":40.86,"amplitude":0.011103,"preClose":40.52,"low":40.4101,"week52Low":27.3,"pbRate":"--","week52High":42.87,"institutionHeld":0,"latestPrice":40.4666,"eps":0,"divideRate":0.010515,"volume":20380,"delay":0,"ttmEps":0,"open":40.86,"prevYearClose":32.9401,"prevWeekClose":41.7742,"prevMonthClose":41.3525,"prevQuarterClose":38.1897,"fiveDayClose":42.2181,"twentyDayClose":40.0288,"sixtyDayClose":35.6657},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTXH\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"FTXH","amount":0.092,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"FTXH","amount":0.0573,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-12-12","symbol":"FTXH","amount":0.1294,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FTXH","amount":0.1453,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-26","symbol":"FTXH","amount":0.0892,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-06-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTXH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0056,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0286,"currency":"USD"},{"executeDate":"2017-03-23","recordDate":"2017-03-27","paymentDate":"2017-03-31","value":0.0313,"currency":"USD"},{"executeDate":"2017-06-22","recordDate":"2017-06-26","paymentDate":"2017-06-30","value":0.0553,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":"2017-09-22","paymentDate":"2017-09-29","value":0.3448,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTXH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTXH\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666031372","title":"Protagonist Therapeutics Launches USD 300 Million Share Buyback Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666031372","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666031372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897932,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics launches USD 300 million share buyback programProtagonist Therapeutics launched a share repurchase program for up to USD 300 million of outstanding common stock.Funding planne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLc74SRP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","TRUH","LU1267930813.SGD","LU2430703095.HKD","IYH","LU1145028129.USD","SG9999001176.SGD","LU1718418525.SGD","FTXH","JNJ","LU0058720904.USD","PJP","IE00BFXG1179.USD","LU1032955483.USD","IHE","LU2487616109.SGD","BK4007","LU0820562030.AUD","XLV","SGXZ80539844.SGD","IE0009355771.USD","FHLC","GDOC","LU0683600562.USD","PTGX","RXL","IE00B42XCP33.USD","IXJ","SG9999001440.SGD","IE0002141913.USD","BMED","LU1551013342.USD","LU1066051225.USD","LU1778281490.HKD","JDOC","LU1057294990.SGD","LU2468319806.SGD","LU0689472784.USD","LU1506573853.SGD","LU2750360641.GBP","LU1244550221.USD","IE00BDGV0183.EUR","VHT","LU2602419157.SGD","IE00B4R5TH58.HKD","IE00B19Z3B42.SGD","IE00BGHQF631.EUR","MEDX","BK4504","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APXH","BME","IBRN","GNOM","SBIO","IBBQ","GPCR","IBBJ","IBB","RSPH","XPH","CURE","MEDI","SURI","GNMX","JDOC","BBH","FHLC","MDTX","MEDX","BIB","MNTL","SYNB","PBE","PJP","JHMH","LFSC","FBT","PSCH","PTH","HYLG","LLYX","GDOC","WDNA","NVIB","MRNY","PSIL","HRTS","PBPH","TBXU","PINK","FTXH","CANC","IEIH","GSKH","CNCR","FXH","AZNH","IDNA","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666631372","title":"Headlands Research Names Brandon Pallott Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2666631372","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666631372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:17","pubTimestamp":1788895060,"startTime":"0","endTime":"0","summary":"Headlands Research names Brandon Pallott chief commercial officerHeadlands Research appointed Brandon Pallott as chief commercial officer to lead business development and commercial strategy, reportin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL75psbm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","SG9999003800.SGD","LU0124676726.USD","LU0320765646.SGD","LU1496350502.SGD","MEDX","AGNG","IYH","LU2347655156.SGD","LU1236620750.USD","LU1162221912.USD","LU0868494708.USD","JDOC","LU2129689514.USD","IE000WAW04H5.SGD","LU0417517546.SGD","SG9999015978.USD","LU1670628061.USD","FTXH","LU0310799852.SGD","FHLC","LU2468319806.SGD","LU2089284900.SGD","IXJ","XLV","LU2237443895.HKD","RXL","LU0965509101.SGD","LU2087621335.USD","LU1023059063.AUD","LU2023251221.USD","IE0002270589.USD","ABBV","SG9999011175.SGD","LU0203345920.USD","VHT","LU0211328371.USD","GLAM","TRUH","IE000F7OJYX1.SGD","BK4585","LU0456855351.SGD","PJP","LU2357627491.SGD","IE00BDGV0183.EUR","BK4588","LU1003077747.HKD","LU0820561818.USD","PPH","LU2089283258.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666914372","title":"Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.25% on Sep 8: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666914372","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666914372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:15","pubTimestamp":1788894935,"startTime":"0","endTime":"0","summary":"• Bristol-Myers Squibb faced profit-taking despite positive Phase 2 trial results for arlocabtagene autoleucel.\n• Investors reacted cautiously due to unspecified regulatory timelines and recent clinical trial enrollment pauses.\n• The company reports $48.19B in annual revenue and maintains solid financial operating metrics.","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262156735-market-movers-bmy-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","LU0061475181.USD","LU2596442595.SGD","IE00BFTCPJ56.SGD","LU0321505868.SGD","LU0096364046.USD","LU0456855351.SGD","LU1585245621.USD","LU1093756168.USD","LU0237698245.USD","LU2242646821.SGD","BK4585","LU0267386448.USD","LU1236620834.HKD","LU1989771016.USD","IE00BSNM7G36.USD","LU1032466523.USD","LU2360032135.SGD","LU1883839398.USD","LU2125154778.USD","LU2242652126.USD","BK4007","LU0432979614.USD","LU1323610961.USD","LU1430594728.SGD","IE00BFXG1179.USD","LU1868836591.USD","LU1093756325.SGD","LU1868836757.USD","BK4532","IE00BJJMRZ35.SGD","LU0882574055.USD","LU1261432733.SGD","LU0985481810.HKD","LU1074936037.SGD","IHE","LU0306806265.USD","LU0114720955.EUR","BK4588","BMY","BK4581","FTXH","LU0868494617.USD","LU1868837300.USD","LU1236620750.USD","LU1670710588.SGD","LU1983299246.USD","BK4534","IE0009355771.USD","IE00BJT1NW94.SGD","LU0306807586.USD","LU0321505439.SGD","LU1670711040.USD","LU1718418525.SGD","LU1291159041.SGD","LU1670710661.SGD","IE0002141913.USD","LU0225284248.USD","LU1868836914.USD","LU1670711123.USD","LU2125154935.USD","LU1868837136.USD","IE00B2B36J28.USD","LU2133065610.SGD","BK4559","LU0225771236.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374281","title":"Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374281","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374281?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:03","pubTimestamp":1788890602,"startTime":"0","endTime":"0","summary":"Cardiovascular disease treatments are potentially lucrative for the pharma industry.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-on-news-of-competitor-novartis-cholesterol-drug-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-on-news-of-competitor-novartis-cholesterol-drug-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WDNA","IE00BK4W5M84.HKD","LU2491050071.SGD","GB00BDT5M118.USD","LU2168564065.EUR","LU2237443895.HKD","IE0002141913.USD","LU2237443622.USD","LU2462157665.USD","LU0058720904.USD","LU2265009873.SGD","LU0203201768.USD","MHIP","LU1989771016.USD","LU0882574055.USD","LU0823434583.USD","LU1988902786.USD","LU0096364046.USD","SGXZ99366536.SGD","MEDX","SG9999015952.SGD","LU1691799644.USD","LU1804176565.USD","IE0004445015.USD","LLY","MEDI","LU0133085943.USD","LU2211815571.USD","LU0823434740.USD","BK4581","LU0210536198.USD","LU2237443978.SGD","IE00BN29S564.USD","SG9999015978.USD","LU0466842654.USD","LU1280957306.USD","SGXZ81514606.USD","IE00BFSS8Q28.SGD","XLV","LU1720051017.SGD","LU1629891620.HKD","LU2023250330.USD","LU2168564495.EUR","FTXH","LU0316494557.USD","LU2213496289.HKD","LU0417517546.SGD","LU0106261372.USD","LU0256863811.USD","LU0266013472.USD","LU2087625088.SGD","BK4516","LU0234572021.USD","LU2089283258.USD","LU2237438978.USD","LU2756315664.SGD","LU0174119429.USD","IE0004445239.USD","LU2028103732.USD","PJP","LU1974910355.USD","IE00BJLML261.HKD","LU0354030511.USD","LU0689472784.USD","LU0203202063.USD","LU2237443465.HKD","LU1548497426.USD","SG9999001176.SGD","IE00B4R5TH58.HKD","LU1868837136.USD","LU2746668974.SGD","HRTS","LU2552382215.SGD","LU0354030438.USD","LU1069344957.HKD","LU2106854487.HKD","LU2491050154.USD","LU2089284900.SGD","IE0001KFT4U8.USD","BK4007","ELIS","IE00BJJMRY28.SGD","OZEM","LU2168564222.USD","IE00BK4W5L77.USD","LU1868837300.USD","LU1868836591.USD","LU1917777945.USD","CURE","LU0353189763.USD","SG9999014880.SGD","LU2552382058.USD","IXJ","LU0889565916.HKD","LU2324357040.USD","LU2357305700.SGD","IE00B2B36J28.USD","LU2750360641.GBP","IE0005OL40V9.USD","LU2361044865.SGD","LU1093756168.USD","SG9999015945.SGD","IE00B7KXQ091.USD","LU0820561909.HKD","LU2417539215.USD","LU0353189680.USD","LU2063271972.USD","LU2361044949.HKD","LU2750360997.AUD","LU1064131342.USD","LU2491049909.HKD","RXL","THNR","AGNG","LU0820561818.USD","LU0158827948.USD","CANC","LU0256863902.USD","LU1712237335.SGD","LU2360106947.USD","IE00BFSS7M15.SGD","IE00BKPKM429.USD","LU0823416689.USD","LU0079474960.USD","SG9999014906.USD","LU0238689110.USD","IE0009355771.USD","LU2471134952.CNY","BK4585","LU2111349929.HKD","LU2237443549.SGD","LU0943347566.SGD","LU0006306889.USD","LU1057294990.SGD","LU0640476718.USD","LU0158827781.USD","LU0323591593.USD","LU2471134796.USD","LU2756315318.SGD","SG9999017495.SGD","SG9999013999.USD","IHE","LLYZ","LU2023251221.USD","LU0109394709.USD","LU2361045086.USD","SG9999018857.SGD","LU2552382132.HKD","LU2023250504.SGD","LU1145028129.USD","TRUH","IE00B775H168.HKD","LU0432979614.USD","LU2168564149.EUR","LU2468319806.SGD","LLII","LU2456880835.USD","SG9999001176.USD","LU2236285917.USD","FHLC","SG9999018865.SGD","LU1267930730.SGD","BK4588","LU2471134879.HKD","LU2112291526.USD","LU0345770993.USD","LU0320765059.SGD","LU0786609619.USD","LU1623119135.USD","LU0787776722.HKD","SGXZ51526630.SGD","LU1035775433.USD","LU1093756325.SGD","LU1979441026.SGD","LU1232071149.USD","IE00BKDWB100.SGD","LU0225283273.USD","LU0122379950.USD","LU0683600562.USD","LU0198837287.USD","LU2746668461.USD","JDOC","LU1366192091.USD","LU2108987350.USD","LU0109391861.USD","LU0471298777.SGD","LU2168563687.JPY","BK4534","IE00B1XK9C88.USD","LU0820562030.AUD","LU1868836914.USD","LU1720051108.HKD","LU1551013425.SGD","LU2237443382.USD","LU0882574139.USD","SG9999015986.USD","LU1551013342.USD","LU2602419157.SGD","LU0345770308.USD","LU1127390331.HKD","SGXZ31699556.SGD","IE00BJJMRX11.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU1061106388.HKD","ELIL","IE00B1BXHZ80.USD","LU0672654240.SGD","VHT","LU1291159041.SGD","LU1023059063.AUD","LU1983299246.USD","IE00B4JS1V06.HKD","LU2264538146.SGD","LU2462591350.SGD","LU0320765992.SGD","LU1323610961.USD","ILDR","LU0114720955.EUR","LU2089984988.USD","LU0094547139.USD","LU0456855351.SGD","LU1868836757.USD","SG9999014914.USD","PPH","IE00BFTCPJ56.SGD","BK4599","LU0061475181.USD","LU0471298694.HKD","LU1814569148.SGD","GDOC","IYH","LU2461242641.AUD","LU0708995401.HKD","IE00BWXC8680.SGD","TMED","LLYX","LU2896262040.SGD","LU0385154629.USD","SG9999014898.SGD","LU2271345857.HKD","SGXZ57979304.SGD","LU2471134523.USD","LU0097036916.USD","BK4533","LU0964807845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665754593","title":"Dow Drops 438 Points on Losses for Amgen, Salesforce Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2665754593","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665754593?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:45","pubTimestamp":1788875100,"startTime":"0","endTime":"0","summary":"DJ Dow Drops 438 Points On Losses For Amgen, Salesforce SharesThis article was automatically generated by MarketWatch using technology from Automated Insights.The Dow Jones Industrial Average is declining Tuesday morning with shares of Amgen and Salesforce seeing the biggest declines for the blue-chip average.Shares of Amgen  and Salesforce  are contributing to the index's intraday decline, as the Dow  was most recently trading 438 points, or 0.8%, lower.Amgen's shares have declined $30.47, or 7.0%, while those of Salesforce have fallen $11.09, or 4.3%, combining for a roughly 247-point drag on the Dow.Also contributing significantly to the decline are Johnson & Johnson , IBM , and Microsoft .A $1 move in any of the Dow's 30 components equates to a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2505996681.GBP","SDY","IE0004445239.USD","IE00B1XK9C88.USD","HK0000304805.HKD","SG9999014880.SGD","LU0345769631.USD","IE000M9KFDE8.USD","MYMmain","LU1778281490.HKD","SG9999014906.USD","IE00B2B36J28.USD","LU1201861165.SGD","SG9999015986.USD","BK4581","LU1935043023.USD","LU0143551892.USD","LU0096364046.USD","LU0345768153.USD","LU2244417387.USD","LU2023250843.SGD","LU1235294995.USD","IE0001KFT4U8.USD","LU2083900584.USD","LU1880398471.USD","LU2023250330.USD","LU0965509283.SGD","LU2750360997.AUD","SG9999014914.USD","LU0511384066.AUD","LU0882574055.USD","LU0432979614.USD","LU0980610538.SGD","FHLC","LU2265009873.SGD","LU0069063385.USD","IE00B775H168.HKD","LU0321505868.SGD","LU2360108059.USD","SG9999014559.SGD","LU2461242641.AUD","VUG","LU2089283258.USD","LU0871640123.AUD","LU1674673428.USD","CNEQ","LU0215105999.USD","LU2237443895.HKD","LU2168564149.EUR","MSFL","IE00B3SWFQ91.USD","LU1430594728.SGD","LU2237443465.HKD","LU1121112475.USD","IE0004445015.USD","LU0882574139.USD","LU1732800096.USD","LU0708994859.HKD","LU0314106906.USD","LU2242652126.USD","SG9999017495.SGD","LU0960925559.SGD","LU0056508442.USD","LU1506573853.SGD","GB00B4QBRK32.GBP","LU0198837287.USD","LU2552382058.USD","LU2361044865.SGD","PJP","LU0965509101.SGD","LU1074936037.SGD","LU0894486033.HKD","IHE","LU0889566641.SGD","IE00B7SZLL34.SGD","LU0061474960.USD","LU0251132253.USD","LU2125909593.SGD","LU0072461881.USD","LU2954938101.SGD","IE000F7OJYX1.SGD","SG9999014575.USD","LU2764263203.CNY","FTXH","GAMR","LU0320765489.SGD","IBX","LU1989773731.SGD","BK4007","BK4554","IE0003U64NQ7.SGD","LU1564329461.SGD","LU1923623000.USD","CRMG","LU0353189763.USD","BK4613","GRNY","IE0002141913.USD","LU0949170426.SGD","LU2433249047.HKD","BK4575","LU0316494557.USD","LU0124676726.USD","WQTM","LU1291159041.SGD","LU0128525929.USD","LU2242650005.HKD","LU2417539215.USD","LU0353189680.USD","LU0158827781.USD","BBH","SG9999018865.SGD","LU1181866309.USD","LU2491050154.USD","IE00BLSP4239.USD","LU0174119429.USD","LU2102340556.USD","LU0238689110.USD","LU0149725797.USD","LU0225283273.USD","LU0323239441.USD","SG9999015952.SGD","LU1894683348.USD","LU1791710582.SGD","LU2111349929.HKD","LU2357305700.SGD","MSFX","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU0823434583.USD","FDN","IE00BKPKM429.USD","LU0820561818.USD","LU1582987324.SGD","IE000KEQY171.SGD","LU0943347566.SGD","LU2999663052.SGD","LU2108987350.USD","EFIV","MSFC","SGXZ81514606.USD","LU0048584097.USD","LU2552382132.HKD","IE00BQXX3C00.GBP","LU0095938881.EUR","LU0138981039.USD","LU1633808545.USD","LU2746668974.SGD","SG9999014542.SGD","LU2403377893.USD","LU1670627923.USD","LU0187121727.USD","HK0000532082.HKD","LU2125154778.USD","LU1803068979.SGD","BK4534","IE000MB6IJN5.SGD","LU2764262908.HKD","IXJ","IE00BZ1G4Q59.USD","LU1564329115.USD","LU2087621335.USD","BK4550","LU2491050071.SGD","LU0052756011.USD","DIA","LU2092937221.SGD","LU1868836914.USD","LU1066051225.USD","LU0345770993.USD","LU2237443382.USD","LU2279689827.SGD","MGK","LU0098860793.USD","LU1061106388.HKD","LU1119994496.HKD","LU2362540622.SGD","LU1235295455.SGD","LU2191332357.HKD","BK4548","BK4559","LU0302445910.USD","LU2720916845.USD","LU1548497426.USD","LU0456855351.SGD","LU2430703095.HKD","SG9999001077.SGD","LU0949170772.SGD","LU1989764664.SGD","LU0256863902.USD","IE00B19Z9505.USD","LU2065170008.USD","LU2092627202.USD","LU1267930813.SGD","IE00B7KXQ091.USD","LU2458330243.SGD","LU3102509885.SGD","LU1188199696.SGD","LU1979441026.SGD","LU0320765059.SGD","DGRO","LU0965508806.USD","NULC","IE00BLSP4452.SGD","LU1935042991.SGD","LU2543165471.USD","LU0823421416.USD","VYMI","LU0203347892.USD","IE00BK4W5L77.USD","BK4585","SGXZ23171101.USD","LU2404859741.USD","LU0210528500.USD","LU1221951046.USD","LU0320765992.SGD","LU0683600562.USD","LU1244550577.SGD","IE0009356076.USD","IE00B3PB1722.GBP","IE000ITXATA3.USD","LU2168564495.EUR","LU1935043452.HKD","IE0002270589.USD","LU0787776722.HKD","LU2168564222.USD","LU2087625088.SGD","LU0757359368.USD","LU1145028129.USD","LU1989763005.USD","SG9999015978.USD","IE00B4YYXB79.USD","LU0082616367.USD","LU1202635105.USD","LU1301847155.USD","LU2361044949.HKD","IE00BFSS8Q28.SGD","LU2097829019.USD","LU2236285917.USD","TBXU","LU0208291251.USD","IE00B3S45H60.SGD","IE00BDRTCR15.USD","LU1316542783.SGD","LU0058720904.USD","LU2125154935.USD","LU2112291526.USD","LU1935042488.USD","LU0472753341.HKD","LU1974910355.USD","LU1066051811.HKD","04332","LU2275660780.HKD","LU2468319806.SGD","DOG","LU0308772762.SGD","LU2237957902.USD","IE00BN8TJ469.HKD","LU0859254822.USD",".DJI","LU2430703178.SGD","AMGN","IE00B4JS1V06.HKD","LU1323610961.USD","IE00B42XCP33.USD","UDOW","SG9999004303.SGD","LU1244550221.USD","VHT","LU2054465674.USD","LU2129689514.USD","LU0079474960.USD","LU1629891620.HKD","LU1823568750.SGD","LU0784385170.HKD","LU0256863811.USD","LU0203345920.USD","LU0690374961.EUR","LU0426412945.USD","BK4588","IE00BJTD4V19.USD","SG9999002224.SGD","LU2250418816.HKD","LU1670711123.USD","LU2125909247.SGD","LU1334329650.SGD","LU0545039389.USD","LU1582987597.SGD","LU2211815571.USD","DGRW","LU2106854487.HKD","LU2237957811.SGD","BK4567","HK0000914686.HKD","LU1228905037.USD","LU1236620750.USD","LU1691799644.USD","LU0784384876.USD","HK0000819398.USD","LU0053666078.USD","LU1582986359.USD","LU0444973449.USD","LU1059921491.USD","LU2458330169.SGD","LU0130517989.USD","LU0122379950.USD","XLI","IE00BYQQ9H92.USD","LU2041044095.USD","IE00BJJMRX11.SGD","LU2065171402.SGD","SG9999001176.USD","LU2746668461.USD","IXN","LU1366192091.USD","IE0034235295.USD","OGIG","LU0661504455.SGD","SG9999018857.SGD","LU2047632596.USD","IE00BFXG1179.USD","LU1923622614.USD","LU2097344431.USD","LU0070217475.USD","LU2271345857.HKD","LU0158827948.USD","LU0170899867.USD","LU1951198990.SGD","IE00B4R5TH58.HKD","LU2357627491.SGD","MEDX","LU0203202063.USD","IE00BFSS7M15.SGD","IE00BK4W5M84.HKD","IE000BZT7R73.USD","LU2506951958.HKD","LU1934455863.HKD","LU0276348264.USD","BK4503","LU2462591350.SGD","LU0965509010.AUD","SG9999015945.SGD","LU0912757837.SGD","LU1564329628.SGD","LU1839511570.USD","BK4568","LU2242649171.HKD","LU1582986433.USD","BK4533","LU0130102774.USD","IGV","IE0005OL40V9.USD","LU0553294199.USD","IE000WAW04H5.SGD","LU0354030511.USD","LU0708995401.HKD","IE00BKVL7J92.USD","LU1670710661.SGD","LU2298321311.HKD","LU0057025933.USD","LU0823417737.USD","LU0265550946.USD","LU0323240290.USD","LU1721428933.USD","IE00BJJMRY28.SGD","TYLG","LU1814569148.SGD","LU0289739699.SGD","LU1037948897.HKD","LU2129689431.USD","TDIV","LU0426417589.USD","LU1674673691.USD","BK4612","IE00BMPRXN33.USD","LU0545562505.USD","BK4505","LU0348723411.USD","TTXU","SG9999015341.SGD","LU1670710588.SGD","DJX","BK4139","BK4579","IE00BQXX3D17.EUR","LU1035775433.USD","LU2764263039.SGD","BK4607","LU0861579265.USD","LU1032955483.USD","LU2552382215.SGD","LU0061475181.USD","LU2023251221.USD","LU2213496289.HKD","LU1366333091.USD","LU2471134952.CNY","IBBQ","LU0395794307.EUR","LU1989772923.USD","SCHG","HK0000914660.USD","LU0130518102.USD","LU2100268510.USD","LU1496350171.SGD","TRUH","BK4532","LU1267930490.SGD","HK0000304797.USD","LU0466842654.USD","LU0784385840.USD","LU1914381329.SGD","LU0788109477.HKD","LU2756315664.SGD","LU1496350502.SGD","SGXZ31699556.SGD","SG9999014567.USD","BK4538","LU0690374615.EUR","LU0077335932.USD","LU2065169927.USD","LU2430703251.USD","LU0823434740.USD","LU0726765562.USD","LU1564329032.USD","IE00BGHQF631.EUR","SGXZ99366536.SGD","BK4516","LU1400636574.HKD","IE00B19Z8X17.USD","LU2023250504.SGD","LU1815336760.USD","LU2210149790.SGD","LU0823421333.USD","LU1988902786.USD","LU0792757196.USD","BK4543","IE00BVYPNW00.USD","LU1032466523.USD","LU1934455194.USD","SG9999001440.SGD","LU0289960550.SGD","LU0795875169.SGD","LU2487616109.SGD","LU0157215616.USD","LU1340139317.AUD","SKYY","SG9999001176.SGD","LU0080751232.USD","LU0894485498.HKD","LU0795875086.SGD","ROM","LU1791710400.SGD","LU0094547139.USD","FDVV","LU0203201768.USD","LU2237438978.USD","MSFT","LU2413666426.HKD","LU1064131342.USD","BK4527","LU2404859667.USD","LU0689626769.HKD","LU0345770308.USD","LU1852331112.SGD","LU2602419157.SGD","LU0310800379.SGD","SG9999000418.SGD","LU0320765646.SGD","LU2413666699.HKD","LU2028103732.USD","LU1935042215.USD","LU1720051108.HKD","LU0289941410.SGD","BK4525","LU0128525689.USD","LU1066051498.USD","LU2462591277.SGD","LU0784383803.USD","LU1880398554.USD","LU1400636491.USD","LU0640476718.USD","LU0109394709.USD","LU0211328371.USD","LU1732799900.SGD","LU2089984988.USD","LU1232071149.USD","LU0342679015.USD","LU2077746001.SGD","LU0312595415.SGD","LU2133065610.SGD","BK4592","LU2637965513.SGD","LU1221951129.SGD","SGXZ57979304.SGD","LU0323591593.USD","LU1228905540.USD","LU1868837300.USD","BK4602","LU1043141123.HKD","BK4561","LU0477156953.USD","IE0000B7K699.USD","LU1244550494.USD","LU2452424414.USD","LU0345774631.USD","LU1043141396.HKD","LU0321505439.SGD","LU2095319765.USD","LU2097344357.USD","BK4599","LU1267930730.SGD","BK4598","LU2750360641.GBP","IE000W1ABFV2.USD","LU1057294990.SGD","IE000SO60NU8.SGD","LU0048573561.USD","DVY","LU0061474705.USD","LU2360032135.SGD","LU1003077747.HKD","MSFD","LU0251142724.SGD","SG9999015358.SGD","LU1066053197.SGD","LU0072462426.USD","TOPT","LU1280957306.USD","LU2347655073.USD","SG9999002232.USD","XLK","IE0004091025.USD","LU0390134368.USD","IBM","BK4134","BIB","LU1989764748.USD","BK4576","SMSFTmain","LU0724617625.USD","LU0029864427.USD","JDOC","LU1815333072.USD","BK4577","LU0345769128.USD","LU1868836591.USD","LU1697837992.HKD","IE00BMPRXR70.SGD","LU1670711040.USD","FTEC","LU0106261372.USD","LU0289961442.SGD","IE0004086264.USD","IE00BWXC8680.SGD","LU2237443978.SGD","LU0823417653.USD","BK4566","LU0154236417.USD","LU1670628061.USD","LU2471134796.USD","SCHD","MSFO","MSFW","LU1069344957.HKD","BK4023","LU2506952170.USD","DDM","LU0957808578.USD","LU2505996509.AUD","LU1571399168.USD","LU2326559502.SGD","LU2168563687.JPY","CMAG","LU0171293334.USD","LU0689472784.USD","LU1201861249.SGD","LU1935043536.SGD","SG9999014898.SGD","LU0310799852.SGD","LU1153585028.USD","LU1670756490.USD","LU0738911758.USD","LU0266013472.USD","LU1162221912.USD","IE00BJTD4N35.SGD","LU0096362180.USD","LU0130103400.USD","LU0648001328.SGD","IYH","IE00BMPRXQ63.HKD","LU0133085943.USD","SGXZ51526630.SGD","LU0251131958.USD","IE00BFXG0V08.USD","LU0234572021.USD","LU0345768740.USD","IE00B5949003.HKD","IE00B3T34201.USD","LU0127658192.USD","LU2362541273.HKD","LU0289739343.SGD","LU1803068623.USD","LU2491049909.HKD","LU2456880835.USD","LU1934455277.USD","LU2089284900.SGD","LU0265550359.USD","GB00BDT5M118.USD","LU1267930227.SGD","SDOW","LU1712237335.SGD","LU2463028550.USD","SIBM0main","LU1645745479.HKD","LU1429558221.USD","LU2471134523.USD","LU1046421795.USD","LU2462157665.USD","LU2168564065.EUR","SG9999001424.SGD","LU2896262040.SGD","LU2237443622.USD","LU1718418525.SGD","LU1400636657.SGD","LU2264538146.SGD","LU1720051017.SGD","LU1196500208.SGD","SNPE","LU0950375773.USD","LU1983260115.SGD","LU2286300806.USD","LU1929549753.HKD","LU0267386448.USD","IE00B775SV38.USD","LU0985320562.USD","LU1868836757.USD","LU2237443549.SGD","DJIA","IE00BHPRN162.USD","LU2129689605.HKD","LU0081259029.USD","IE0034235303.USD","LU1236620834.HKD","LU0642271901.SGD","DXD","BMED","LU0354030438.USD","IE0009355771.USD","LU1983299246.USD","BK4608","LU0314104364.USD","IE00BFTCPJ56.SGD","LU1642822529.SGD","LU1868837136.USD","IE00B1BXHZ80.USD","LU0070302665.USD","LU0868494617.USD","LU0114720955.EUR","SG9999013999.USD","BK4535","BK4528","LU2347655156.SGD","LU2506951875.HKD","LU0310800965.SGD","LU1116320737.USD","LU1116320901.HKD","LU0557290698.USD","BK4097","LU0820562030.AUD","LU0889565916.HKD","LU0210533765.USD","LU1804176565.USD","BK4504","LU0889565833.HKD","LU2092937148.SGD","LU2063271972.USD","IE0034235188.USD","RXL","IE00BYXW3230.USD","LU0757359954.USD","LU0476273544.USD","LU1435385759.SGD","IE00B5TLWC47.USD","LU0494093205.USD","LU0347712357.USD","LU2361045086.USD","LU0175139822.USD","LU2420271590.USD","IE00BJLML261.HKD","YMAX","LU0648000940.SGD","LU1861127337.USD","IE00BDCRKT87.USD","LU2592432038.USD","LU0162691827.USD","LU0444971666.USD","LU1037948541.HKD","LU0011850046.USD","IE00B19Z3581.USD","LU0107464264.USD","LU0211327993.USD","LU0345774391.USD","LU1623119135.USD","LU0672654240.SGD","IE00B19Z8W00.USD","PBE","LU2247934214.USD","LU0477156797.USD","LU2242646821.SGD","LU2362541513.USD","LU2065171311.SGD","SPTE","CRM","LU0994945656.USD","LU2471134879.HKD","LU1989771016.USD","IE00BKDWB100.SGD","LU1023059063.AUD","LU1883839398.USD","MSFY","LU0234570918.USD","IE00BN29S564.USD","LU0528227936.USD","LU2860962120.EUR","IE0009G5SDU7.USD","LU0417517546.SGD","MSFU","LU1261432733.SGD","LU1551013342.USD","GDOC","LU0097036916.USD","LU2360106780.USD","LU1894683264.USD","LU1917777945.USD","LU2210150020.SGD","LU2756315318.SGD","VYM","SGXZ80539844.SGD","LU1069347547.HKD","LU0820561909.HKD","LU0879622024.SGD","LU0006306889.USD","LU0211331839.USD","LU1551013425.SGD","LU0109391861.USD","IE000YTNTUN2.SGD","GB00B4LPDJ14.GBP","LU1267930573.SGD","LU0957791311.USD","LU1127390331.HKD","IBB","LU1035773651.USD","IE00BDGV0183.EUR","LU0742534661.SGD","LU1084165304.USD","LU2381873111.SGD","LU1585245621.USD","LU2148611432.USD","IE00B19Z3B42.SGD","IE00BVYPNV92.GBP","VGT","LU2506952097.USD","IE00BJT1NW94.SGD","LU1951200564.SGD","IE00BQXX3F31.USD","LU1989772840.SGD","BK4587","JNJ","LU0964807845.USD","LU0109392836.USD","XLV","LU0210536198.USD","LU0719512351.SGD","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HRTS","FHLC","BME","FTXH","PJP","BIB","TBXU","PSCH","GSKH","CANC","AZNH","IBB","GNOM","NVIB","IBBQ","WDNA","FXH","PBE","CNCR","PBPH","PTH","LENZ","APXH","SBIO","LLYX","BBH","IDNA","CURE","GPCR","PINK","SURI","LFSC","JHMH","MEDX","IBBJ","XPH","SYNB","PSIL","MRNY","FBT","MDTX","MEDI","MNTL","JDOC","IBRN","HYLG","GNMX","BBP","RSPH","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327289","title":"Johnson & Johnson Innovation Names Silvia Chen Head of JLABS Shanghai","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327289","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327289?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:43","pubTimestamp":1788867829,"startTime":"0","endTime":"0","summary":"Johnson & Johnson Innovation names Silvia Chen head of JLABS ShanghaiJohnson & Johnson Innovation-JJDC appointed Silvia Chen as site head of JLABS Shanghai.Chen brings more than two decades in healthc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL9xctQs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1718418525.SGD","LU0820561909.HKD","IE00BZ1G4Q59.USD","LU1066051498.USD","LU1496350502.SGD","XLV","LU1551013425.SGD","LU2089984988.USD","JDOC","LU0820562030.AUD","LU2456880835.USD","RXL","IXJ","VHT","BMED","LU0203345920.USD","FHLC","IE00B3T34201.USD","LU0426412945.USD","LU0640476718.USD","IHE","LU2471134523.USD","TRUH","LU0432979614.USD","LU1244550577.SGD","IE00B19Z3581.USD","FTXH","LU2505996509.AUD","IYH","LU0795875169.SGD","BK4504","LU0882574055.USD","IE000SO60NU8.SGD","LU1043141396.HKD","MEDX","LU2471134952.CNY","LU2750360641.GBP","LU0345770993.USD","LU2505996681.GBP","GDOC","LU1280957306.USD","LU0058720904.USD","LU1674673428.USD","LU0689626769.HKD","PJP","LU2129689605.HKD","LU0210528500.USD","JNJ","IE0009355771.USD","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665473327","title":"Bristol Myers Squibb's Phase 2 Study of Arlocabtagene Autoleucel Meets Key Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2665473327","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665473327?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:41","pubTimestamp":1788867677,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb  said Tuesday that its CAR-T cell therapy arlocabtagene autoleucel met the primary and secondary endpoints of a phase 2 trial to treat adults with quadruple-class exposed relapsed and refractory multiple myeloma.The company said the study's results met its primary endpoint of demonstrating a statistically significant and clinically meaningful overall response rate in heavily pretreated adults with the blood cancer with at least four lines of therapy. It also said the study met key secondary endpoints, including a complete response rate in patients with at least three previous lines of therapy.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1236620834.HKD","BMY","LU1291159041.SGD","LU0868494617.USD","LU1430594728.SGD","LU1868836914.USD","LU0985481810.HKD","LU0096364046.USD","BK4588","FTXH","LU0267386448.USD","LU1883839398.USD","LU0237698245.USD","LU2125154935.USD","BK4559","LU1989771016.USD","IE00BJJMRZ35.SGD","LU1670711123.USD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","BK4581","LU1236620750.USD","BK4585","LU1323610961.USD","LU2242652126.USD","LU0321505439.SGD","IE00B2B36J28.USD","LU1868836757.USD","LU0432979614.USD","LU1032466523.USD","LU1093756325.SGD","LU1718418525.SGD","LU0306806265.USD","BK4007","LU1868837300.USD","LU0882574055.USD","LU1585245621.USD","LU1868836591.USD","LU1571399168.USD","LU1670711040.USD","LU1074936037.SGD","IHE","LU0306807586.USD","LU1261432733.SGD","IE0002141913.USD","LU0225284248.USD","LU1868837136.USD","LU0225771236.USD","LU1670710588.SGD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327821","title":"Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327821","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327821?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:11","pubTimestamp":1788865885,"startTime":"0","endTime":"0","summary":"Bristol Myers (BMY) announced positive Phase 2 results from the registrational QUINTESSENTIAL trial of arlocabtagene autoleucel in adult patients w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-arlocabtagene-autoleucel-shows-positive-results-in-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-arlocabtagene-autoleucel-shows-positive-results-in-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1718418525.SGD","BK4588","LU0267386448.USD","LU2133065610.SGD","LU0882574055.USD","LU1261432733.SGD","LU1093756325.SGD","BBC","LU1093756168.USD","LU1670710588.SGD","LU2596442595.SGD","MYE","BK4585","LU1670710661.SGD","LU1883839398.USD","LU1032466523.USD","LU0237698245.USD","BK4534","LU0456855351.SGD","LU1868837300.USD","BMY","LU1989771016.USD","LU1868836914.USD","IE00BFTCPJ56.SGD","PSIL","LU1983299246.USD","FTXH","BK4559","IHE","LU1236620834.HKD","LU0114720955.EUR","LU1291159041.SGD","LU1074936037.SGD","LU1430594728.SGD","LU1236620750.USD","LU0985481810.HKD","LU2242652126.USD","LU0321505868.SGD","LU0432979614.USD","IE0002141913.USD","LU2125154935.USD","BK4126","IE00BJJMRZ35.SGD","LU0868494617.USD","LU1670711123.USD","LU2360032135.SGD","LU0061475181.USD","LU0225284248.USD","IE0009355771.USD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665832218","title":"Bristol Myers Squibb's Therapy Meets Mid-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2665832218","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665832218?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:03","pubTimestamp":1788865386,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb's therapy meets mid-stage trial goalSept 8 (Reuters)-Bristol Myers SquibbBMY.Nsaid on Tuesday its experimental cell therapy met the main goal of a mid-stage trial.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500S1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","IE00BJJMRZ35.SGD","LU0237698245.USD","LU1670711123.USD","LU1989771016.USD","LU0306806265.USD","LU1670710588.SGD","LU1983299246.USD","LU0061475181.USD","BK4588","LU0432979614.USD","LU1883839398.USD","LU1093756168.USD","BK4585","LU0225284248.USD","LU1868836591.USD","LU1261432733.SGD","LU0985481810.HKD","LU1868836914.USD","LU0882574055.USD","LU1718418525.SGD","IHE","IE0002141913.USD","LU2596442595.SGD","LU1670710661.SGD","LU0868494617.USD","LU1074936037.SGD","LU1236620750.USD","LU0096364046.USD","LU1430594728.SGD","LU2360032135.SGD","LU2125154935.USD","BMY","LU1868837300.USD","LU2242652126.USD","LU2133065610.SGD","IE00BFTCPJ56.SGD","LU0114720955.EUR","LU1093756325.SGD","BK4534","IE00BSNM7G36.USD","LU1032466523.USD","LU1291159041.SGD","LU0321505868.SGD","IE0009355771.USD","LU1236620834.HKD","LU0267386448.USD","LU0306807586.USD","LU0456855351.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322873","title":"Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 Quintessential Trial of the Potential First-in-Class Gprc5d-Directed Car T Cell Therapy, Arlocabtagene Autoleucel ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322873?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:59","pubTimestamp":1788865140,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA7SSM6X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0002141913.USD","LU2125154778.USD","IE00BJT1NW94.SGD","LU1883839398.USD","LU1670711040.USD","IE0009355771.USD","LU0096364046.USD","LU1670710661.SGD","LU0267386448.USD","BMY","LU0321505868.SGD","LU1291159041.SGD","LU1236620834.HKD","LU1670711123.USD","LU1074936037.SGD","LU1430594728.SGD","LU1983299246.USD","LU0985481810.HKD","LU0456855351.SGD","IE00BFXG1179.USD","LU0868494617.USD","LU0432979614.USD","LU2596442595.SGD","LU0321505439.SGD","LU1261432733.SGD","LU1032466523.USD","LU0114720955.EUR","LU0306806265.USD","BK4588","IE00B2B36J28.USD","LU2242652126.USD","LU1236620750.USD","LU2125154935.USD","IHE","LU1868836591.USD","LU1989771016.USD","FTXH","IE00BSNM7G36.USD","LU1093756168.USD","LU1868837300.USD","IE00BJJMRZ35.SGD","LU0237698245.USD","BK4534","LU2242646821.SGD","BK4581","LU0225284248.USD","LU1093756325.SGD","LU2133065610.SGD","IE00BFTCPJ56.SGD","LU1323610961.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322827","title":"Bristol-Myers Squibb Company - Phase 2 Trial Met Primary Endpoint of Overall Response Rate and Complete Response Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322827","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322827?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:59","pubTimestamp":1788865140,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA7SSM6X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1983299246.USD","LU1868837300.USD","LU1868836914.USD","IHE","IE00BFXG1179.USD","LU0985481810.HKD","LU2242646821.SGD","LU1670710661.SGD","IE0002141913.USD","LU1585245621.USD","LU1989771016.USD","LU0321505439.SGD","LU0237698245.USD","LU0096364046.USD","LU1074936037.SGD","LU0306806265.USD","BK4585","LU1670711040.USD","LU0456855351.SGD","LU1670711123.USD","IE0009355771.USD","IE00BJT1NW94.SGD","LU1032466523.USD","LU0061475181.USD","IE00BSNM7G36.USD","LU1571399168.USD","LU1236620834.HKD","LU0267386448.USD","LU0306807586.USD","LU1323610961.USD","LU2125154778.USD","LU2360032135.SGD","FTXH","LU0225771236.USD","LU1093756168.USD","BMY","IE00BJJMRZ35.SGD","BK4581","LU0225284248.USD","BK4534","LU2133065610.SGD","BK4559","LU0432979614.USD","LU1868836591.USD","BK4532","LU0882574055.USD","LU1236620750.USD","LU2242652126.USD","LU1291159041.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322824","title":"Bristol-Myers Squibb Company - Arlo-Cel Safety Profile Consistent with Other Car T Cell Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322824","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322824?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:59","pubTimestamp":1788865140,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA7SSM6X:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0061475181.USD","IE00BFTCPJ56.SGD","LU0321505868.SGD","LU0096364046.USD","LU0456855351.SGD","LU1093756168.USD","LU0237698245.USD","LU2242646821.SGD","BK4585","LU0267386448.USD","LU1236620834.HKD","IE00BSNM7G36.USD","LU2360032135.SGD","LU2125154778.USD","LU2242652126.USD","BK4007","LU0432979614.USD","LU1323610961.USD","LU1430594728.SGD","LU1868836591.USD","LU1868836757.USD","BK4532","IE00BJJMRZ35.SGD","LU0882574055.USD","LU0985481810.HKD","LU1074936037.SGD","IHE","LU0306806265.USD","LU0114720955.EUR","BMY","LU0868494617.USD","LU1868837300.USD","FTXH","LU1236620750.USD","LU1670710588.SGD","LU1983299246.USD","IE0009355771.USD","IE00BJT1NW94.SGD","LU0306807586.USD","LU0321505439.SGD","LU1670711040.USD","LU1718418525.SGD","LU1291159041.SGD","IE0002141913.USD","LU1868836914.USD","LU1670711123.USD","LU2125154935.USD","IE00B2B36J28.USD","LU2133065610.SGD","LU0225771236.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665532264","title":"Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.","url":"https://stock-news.laohu8.com/highlight/detail?id=2665532264","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665532264?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:58","pubTimestamp":1788865080,"startTime":"0","endTime":"0","summary":"Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgeryBoomers are the suddenly the fastest-growing customers for cosmetic surgery.Baby boomers are the wealthiest ge","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","LU2357627491.SGD","LU2089284900.SGD","LU1244550221.USD","VHT","BK4550","LU1093756168.USD","LU1732800096.USD","BK4585","LU0234570918.USD","LU0949170772.SGD","IE00B19Z3B42.SGD","IXJ","SG9999015978.USD","LU0965508806.USD","LU1929549753.HKD","LU0154236417.USD","LU0289961442.SGD","IE00BGHQF631.EUR","LU1989772840.SGD","LU1670627923.USD","LU2324357040.USD","LU0511384066.AUD","LU0795875169.SGD","LU0395794307.EUR","LU0545039389.USD","LU1934455277.USD","LU1732799900.SGD","LU2129689514.USD","BK4588","LU1236620750.USD","LU0203347892.USD","IE000WAW04H5.SGD","RXL","LU1023059063.AUD","LU0124676726.USD","LU0795875086.SGD","LU2129689605.HKD","IE00BN8TJ469.HKD","LU2023251221.USD","IE0002141913.USD","LU2237443465.HKD","LU0058720904.USD","LU1244550494.USD","LU0170899867.USD","LU0320765646.SGD","LU0289739343.SGD","LU0820561818.USD","LU0965509101.SGD","LU1934455194.USD","LU0553294199.USD","LU2125909593.SGD","IE00BDGV0183.EUR","LU2129689431.USD","SG9999015952.SGD","MEDX","PJP","LU0456855351.SGD","NVOH","IE00B3PB1722.GBP","SG9999003800.SGD","IYH","IE00BLSP4452.SGD","LU0432979614.USD","LU1430594728.SGD","OZEM","SG9999011175.SGD","GLAM","LU2089984988.USD","LU1074936037.SGD","SG9999015986.USD","LU1989772923.USD","IE0004445239.USD","LU0029864427.USD","IE00BVYPNW00.USD","LU1923622614.USD","IE00BBT3K403.USD","LU1551013342.USD","LU0726765562.USD","LU1003077747.HKD","THNR","IE0009355771.USD","IE00BJT1NW94.SGD","LU0689472784.USD","LU1061106388.HKD","XLV","LU0985320562.USD","IE00BVYPNV92.GBP","LU0122379950.USD","NVOC","LU1496350502.SGD","IE00B19Z3581.USD","LU1037948541.HKD","LU0861579265.USD","BK4533","LU0198837287.USD","LU0203345920.USD","IE0000B7K699.USD","LU0310799852.SGD","LU0057025933.USD","LU0128525929.USD","LU0859254822.USD","LU1267930490.SGD","LU2133065610.SGD","PPH","IE00B42XCP33.USD","LU0965509010.AUD","LU0965509283.SGD","LU1162221912.USD","LU0943347566.SGD","LU2237443622.USD","LU0310800379.SGD","LU2089283258.USD","LU1585245621.USD","ESTA","LU0738911758.USD","AGNG","IE00BSNM7G36.USD","LU1244550577.SGD","IE000BZT7R73.USD","LU2087621335.USD","LU1093756325.SGD","BK4532","LU0882574055.USD","ABBV","BK4198","BK4581","LU0942090050.USD","LU1551013425.SGD","TRUH","LU1983299246.USD","NVO","LU0158827948.USD","SG9999001440.SGD","LU1291159041.SGD","LU0256863811.USD","IE00B4R5TH58.HKD","LU0211327993.USD","LU0256863902.USD","LU0417517546.SGD","LU0820561909.HKD","LU0098860793.USD","LU0823416689.USD","BK4139","IE0002270589.USD","LU0211328371.USD","LU1267930573.SGD","LU1496350171.SGD","LU2112291526.USD","IE00B2B36J28.USD","BK4599","LU0868494708.USD","LU0234572021.USD","BK4559","LU2468319806.SGD","IE000F7OJYX1.SGD","LU2347655156.SGD","IE00BFTCPJ56.SGD","SG9999015945.SGD","LU2433249047.HKD","LU0069063385.USD","LU0689626769.HKD","LU0708994859.HKD","BK4566","LU0912757837.SGD","LU1236620834.HKD","LU2237443895.HKD","LU1989771016.USD","IE000MB6IJN5.SGD","LU1037948897.HKD","IE00BZ1G4Q59.USD","BK4007","FHLC","GALDY","IE00BJJMRZ35.SGD","LU0661504455.SGD","LU1839511570.USD","LU2125909247.SGD","LU0472753341.HKD","LU1057294990.SGD","LU0114720955.EUR","LU0868494617.USD","LU2237443549.SGD","FTXH","BK4534","LU2347655073.USD","LU2237443978.SGD","IE000SO60NU8.SGD","LU1718418525.SGD","LU2237443382.USD","LU1934455863.HKD","LU1670628061.USD","NVOX","IE00BKVL7J92.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665242473","title":"Merck CEO Davis, R&D Head Li to Speak at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665242473","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665242473?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:45","pubTimestamp":1788864348,"startTime":"0","endTime":"0","summary":"Merck CEO Davis, R&D head Li to speak at Morgan Stanley Global Healthcare ConferenceMerck will join Morgan Stanley’s 24th Annual Global Healthcare Conference on Sept. 14, 2026.CEO Robert M. Davis will","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL445tZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2491049909.HKD","SG9999015341.SGD","BK4550","LU1941712264.USD","LU2361044865.SGD","SG9999002224.SGD","IE00BFTCPJ56.SGD","LU0648001328.SGD","IE00BLSP4452.SGD","SG9999002232.USD","IE00B4R5TH58.HKD","LU0203347892.USD","LU1116320737.USD","LU2023250504.SGD","LU1571399168.USD","PPH","SG9999001176.SGD","LU1430594728.SGD","IHE","LU0289739699.SGD","IE0002141913.USD","FTXH","LU1037948541.HKD","LU0098860793.USD","LU0006306889.USD","LU0868494617.USD","SG9999014542.SGD","LU2023250843.SGD","IE00BN8TJ469.HKD","LU1035773651.USD","LU0208291251.USD","LU1941712348.USD","IE00BBT3K403.USD","IE00BJJMRZ35.SGD","LU0859254822.USD","LU2125154935.USD","LU0965508806.USD","LU1989772840.SGD","LU0265550946.USD","IXJ","LU1057294990.SGD","BK4534","LU1201861249.SGD","LU0266013472.USD","LU1974910355.USD","LU1093756168.USD","LU1934455863.HKD","BK4516","RXL","SG9999014559.SGD","MRK","IE000M9KFDE8.USD","LU1989771016.USD","LU0689626769.HKD","SGXZ57979304.SGD","IE0009355771.USD","LU1066051811.HKD","LU1585245621.USD","LU2106854487.HKD","LU0211331839.USD","LU0234572021.USD","LU0070302665.USD","LU1699723380.USD","LU2125909247.SGD","LU1929549753.HKD","JDOC","LU1032466523.USD","LU2491050071.SGD","LU0320765646.SGD","LU0238689110.USD","LU1917777945.USD","LU0823416689.USD","LU2491050154.USD","SG9999013999.USD","LU2125909593.SGD","BK4007","LU1934455194.USD","LU0122379950.USD","LU1162221912.USD","IE00BLSP4239.USD","LU0868494708.USD","LU0965509101.SGD","LU2324357040.USD","LU2357627491.SGD","LU2361044949.HKD","IYH","BK4588","LU0432979614.USD","LU1066053197.SGD","IE00B2B36J28.USD","LU1069347547.HKD","IE00B1BXHZ80.USD","LU0320765489.SGD","VHT","BMED","LU1061106388.HKD","LU0130102774.USD","LU0058720904.USD","LU1291159041.SGD","IE00BSNM7G36.USD","LU1037948897.HKD","LU2360032135.SGD","LU0980610538.SGD","LU2361045086.USD","LU0265550359.USD","TRUH","LU2089984988.USD","LU0106261372.USD","LU0965509283.SGD","LU2461242641.AUD","LU1989772923.USD","SG9999001176.USD","HRTS","LU2468319806.SGD","LU1023059063.AUD","LU0861579265.USD","FHLC","LU2433249047.HKD","LU1116320901.HKD","LU0965509010.AUD","LU0124676726.USD","LU0477156953.USD","LU1093756325.SGD","SG9999001440.SGD","LU0203345920.USD","LU2112291526.USD","BK4585","PAWZ","IE00BJT1NW94.SGD","SG9999014567.USD","SG9999014575.USD","LU1066051225.USD","LU1983299246.USD","LU1934455277.USD","GDOC","BK4533","LU2125154778.USD","XLV","LU1923622614.USD","BK4559","LU0985320562.USD","LU0130517989.USD","SG9999015358.SGD","LU1066051498.USD","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665324477","title":"Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2665324477","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665324477?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:42","pubTimestamp":1788864129,"startTime":"0","endTime":"0","summary":"Merck & Co. (MRK) has an average rating of overweight and mean price target of $149.44, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0238689110.USD","IE0009355771.USD","SG9999014542.SGD","LU2106854487.HKD","LU1917777945.USD","RXL","LU0130517989.USD","SG9999015341.SGD","LU2491049909.HKD","LU1116320901.HKD","LU1066053197.SGD","IE00B2B36J28.USD","LU1571399168.USD","LU0265550359.USD","SGXZ57979304.SGD","PAWZ","LU0266013472.USD","BK4588","LU0289739699.SGD","LU1201861249.SGD","LU1929549753.HKD","LU1035773651.USD","LU0861579265.USD","LU2357627491.SGD","SG9999001176.SGD","LU1023059063.AUD","LU2324357040.USD","VHT","LU1983299246.USD","IE00BJT1NW94.SGD","LU0124676726.USD","LU1934455194.USD","LU0689626769.HKD","LU1989772840.SGD","IE00BFTCPJ56.SGD","BK4007","LU1057294990.SGD","LU0070302665.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","IXJ","LU1093756168.USD","LU0211331839.USD","LU0432979614.USD","LU2468319806.SGD","SG9999014559.SGD","XLV","BK4550","LU1923622614.USD","LU0106261372.USD","LU2491050154.USD","SG9999014567.USD","LU1032466523.USD","LU2361045086.USD","IE000M9KFDE8.USD","JDOC","LU0868494617.USD","IE00BBT3K403.USD","LU2433249047.HKD","LU2491050071.SGD","IE00B1BXHZ80.USD","LU2461242641.AUD","LU1934455863.HKD","LU2361044949.HKD","SG9999001176.USD","LU0859254822.USD","BK4533","LU2023250504.SGD","SG9999014575.USD","LU1066051498.USD","LU0234572021.USD","LU1066051811.HKD","LU0965509101.SGD","TRUH","LU2089984988.USD","LU1061106388.HKD","LU0320765646.SGD","LU1430594728.SGD","LU0965509283.SGD","BMED","LU1116320737.USD","LU1069347547.HKD","LU2361044865.SGD","HRTS","LU0823416689.USD","BK4585","LU1941712264.USD","LU0122379950.USD","LU0265550946.USD","IE00B4R5TH58.HKD","SG9999015358.SGD","LU2125909247.SGD","LU1066051225.USD","LU2125154935.USD","IE00BLSP4239.USD","GDOC","LU0965509010.AUD","LU1699723380.USD","IE00BLSP4452.SGD","LU2023250843.SGD","LU1162221912.USD","MRK","LU1989772923.USD","SG9999002224.SGD","LU0980610538.SGD","LU1585245621.USD","BK4534","IE0002141913.USD","BK4559","LU0058720904.USD","LU1934455277.USD","BK4516","IHE","SG9999001440.SGD","IE00BN8TJ469.HKD","LU1989771016.USD","LU0868494708.USD","SG9999002232.USD","IE00BSNM7G36.USD","LU2360032135.SGD","LU0203345920.USD","LU2112291526.USD","LU0320765489.SGD","LU0203347892.USD","IYH","LU1037948541.HKD","LU2125154778.USD","LU0648001328.SGD","LU1037948897.HKD","LU0098860793.USD","LU1974910355.USD","LU0006306889.USD","FTXH","LU2125909593.SGD","SG9999013999.USD","LU0130102774.USD","LU0477156953.USD","LU1941712348.USD","FHLC","LU0942090050.USD","LU0985320562.USD","LU1291159041.SGD","PPH","LU0965508806.USD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665210433","title":"Abbvie : Bofa Global Research Raises Price Objective to $282.00 from $276.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2665210433","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665210433?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:21","pubTimestamp":1788862905,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nAZN4TIY57:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999003800.SGD","LU0211328371.USD","IE0002270589.USD","LU0965509101.SGD","IE00B19Z3B42.SGD","PPH","IE000WAW04H5.SGD","LU1934455277.USD","IE00BLSP4452.SGD","AGNG","FHLC","IXJ","LU1718418525.SGD","LU1989771016.USD","LU2433249047.HKD","FTXH","LU0114720955.EUR","IE00BFTCPJ56.SGD","LU0211327993.USD","LU0203347892.USD","IE00B4R5TH58.HKD","LU0289961442.SGD","IE00BVYPNV92.GBP","IYH","LU2237443382.USD","PJP","LU2129689431.USD","LU0553294199.USD","IE00BGHQF631.EUR","LU1037948541.HKD","MEDX","LU1839511570.USD","TRUH","LU1236620834.HKD","LU1267930490.SGD","LU0708994859.HKD","GLAM","RXL","JDOC","LU2468319806.SGD","LU2237443978.SGD","XLV","LU1929549753.HKD","IE00BN8TJ469.HKD","ABBV","VHT","LU0289739699.SGD","LU1093756325.SGD","LU1061106388.HKD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665281321","title":"Merck & Co Inc : Guggenheim Raises Target Price to $170 from $146","url":"https://stock-news.laohu8.com/highlight/detail?id=2665281321","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665281321?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:15","pubTimestamp":1788862514,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN4500A6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LU1116320901.HKD","LU1989772923.USD","LU0859254822.USD","LU0265550359.USD","LU1699723380.USD","SG9999014575.USD","LU0208291251.USD","LU0965509101.SGD","LU1066053197.SGD","LU0320765489.SGD","LU1974910355.USD","LU0868494708.USD","BMED","LU0130102774.USD","LU0477156953.USD","LU0648001328.SGD","LU2125909593.SGD","LU0689626769.HKD","LU0965509010.AUD","LU2023250843.SGD","LU1162221912.USD","SG9999014559.SGD","LU0203345920.USD","LU0823416689.USD","LU0070302665.USD","LU2106854487.HKD","IE0002141913.USD","LU0980610538.SGD","LU0265550946.USD","SG9999015358.SGD","IE00BJT1NW94.SGD","LU1057294990.SGD","LU1061106388.HKD","LU0320765646.SGD","LU0124676726.USD","LU1069347547.HKD","FHLC","LU0965509283.SGD","LU1430594728.SGD","LU2357627491.SGD","SG9999002224.SGD","IE00BLSP4452.SGD","LU2433249047.HKD","BK4534","BK4550","LU2461242641.AUD","LU1037948541.HKD","RXL","IE00B2B36J28.USD","PPH","LU1917777945.USD","LU0432979614.USD","LU1989771016.USD","BK4588","LU2125154935.USD","HRTS","BK4585","IE0009355771.USD","IHE","SG9999002232.USD","LU0985320562.USD","LU0238689110.USD","LU1066051498.USD","LU0006306889.USD","LU0106261372.USD","BK4559","LU0266013472.USD","IE00B1BXHZ80.USD","LU1201861249.SGD","LU0098860793.USD","LU1941712348.USD","LU1037948897.HKD","IE00BLSP4239.USD","LU2361044949.HKD","LU1093756325.SGD","LU2360032135.SGD","LU1066051225.USD","LU1941712264.USD","BK4533","LU0130517989.USD","LU1023059063.AUD","IE00BSNM7G36.USD","BK4516","LU0965508806.USD","LU2324357040.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU1934455863.HKD","IE00BJJMRZ35.SGD","IXJ","LU2491050071.SGD","LU2361045086.USD","LU0122379950.USD","LU2491049909.HKD","LU0211331839.USD","LU0861579265.USD","LU1291159041.SGD","LU0942090050.USD","LU1571399168.USD","SG9999014567.USD","LU1116320737.USD","LU0234572021.USD","VHT","LU2491050154.USD","SGXZ57979304.SGD","LU0289739699.SGD","SG9999001176.USD","TRUH","LU1066051811.HKD","LU1093756168.USD","LU0058720904.USD","LU1989772840.SGD","LU1032466523.USD","SG9999015341.SGD","SG9999001440.SGD","MRK","XLV","LU1934455277.USD","SG9999001176.SGD","LU2089984988.USD","LU2112291526.USD","LU1923622614.USD","LU2361044865.SGD","LU2468319806.SGD","IE00BBT3K403.USD","LU1035773651.USD","IE00BN8TJ469.HKD","LU1983299246.USD","IE000M9KFDE8.USD","LU1585245621.USD","IYH","LU2125909247.SGD","SG9999013999.USD","LU0203347892.USD","IE00B4R5TH58.HKD","FTXH","LU2023250504.SGD","LU1934455194.USD","GDOC","SG9999014542.SGD","LU2125154778.USD","PAWZ","JDOC","LU1929549753.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665232106","title":"Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665232106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665232106?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:10","pubTimestamp":1788862214,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Ther...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-royalty-pharma-rprx-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-royalty-pharma-rprx-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1929549753.HKD","IXJ","LU0128525929.USD","PJP","LU0861579265.USD","FHLC","IYH","LU0859254822.USD","LU1291159041.SGD","IE00B3PB1722.GBP","AGNG","FTXH","BK4550","LU0965509010.AUD","RXL","BK4137","HCSG","IE00BVYPNV92.GBP","MEDX","LU1551013342.USD","LU0211328371.USD","SMMT","JDOC","LU0211327993.USD","XBI","LU1037948897.HKD","ABBV","LU0553294199.USD","LU2237443549.SGD","VHT","TRUH","LU0417517546.SGD","IE0004445239.USD","LU0029874061.USD","LU2433249047.HKD","RPRX","LABU","IE000BZT7R73.USD","LU1057294990.SGD","PPH","LU1244550494.USD","LU1003077747.HKD","GLAM","IHE","XLV","LU0823416689.USD","LU0689626769.HKD","LU2347655073.USD","PBE","LU2125909247.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}